Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App
Success
Alert
Please select a Day.
Info

Aarey Drugs and Pharmaceuticals Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE

37/100
69.85
3.14 (4.71%)

As on 07 Jan, 2026 | 03:52

Open Trading A/c
Day Range
66.17
70.04
L H
52 Week Range
31.35
100.00
L H
Volume
436,306
*
i

* BSE Market Depth (07 Jan 2026)

BUY SELL
QTY PRICE PRICE QTY
500 68.01 69.65 10
1008 68.00 0.00 0
100 66.50 0.00 0
10 65.00 0.00 0
50 64.30 0.00 0
0 Total Total 0
Bid / Ask
0.00 / 0.00
37/100
69.00
2.66 (4.01%)

As on 07 Jan, 2026 | 04:01

Open Trading A/c
Day Range
66.16
69.65
L H
52 Week Range
31.30
100.00
L H
Volume
15,988
*
i

* BSE Market Depth (07 Jan 2026)

BUY SELL
QTY PRICE PRICE QTY
500 68.01 69.65 10
1008 68.00 0.00 0
100 66.50 0.00 0
10 65.00 0.00 0
50 64.30 0.00 0
0 Total Total 0
Bid / Ask
0.00 / 0.00
NSE
MC Essentials
35% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, Low Growth Trend Stock Priced at Expensive Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 66.71
          Previous Close 66.71
          Volume 436,306.00
          Value (Lacs) 304.76
            VWAP 68.63
          Beta
          Mkt Cap (Rs. Cr.) 198
          High 70.04
          Low 66.17
          UC Limit 70.04
          LC Limit 63.38
          52 Week High 100.00
          52 Week Low 31.35
          Face Value 10.00
          All Time High 100.00
          All Time Low 29.95
          20D Avg Volume 322,185
          20D Avg Delivery(%) 72.92
          Book Value Per Share --
          Dividend Yield 0.00
          TTM EPS See historical trend 0.00 (-41.18% YoY)
          TTM PE See historical trend -- (High PE)
          P/B See historical trend 0.00 (High P/B)
          Sector PE 40.49

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          37/100
          Average Financial Strength, Low Growth Trend Stock Priced at Expensive Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 30.15% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Below Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 44.80% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          1 out of 3 years Aarey Drugs and Pharmaceuticals has given negative returns in January.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          January 4.85% (2024) 4.85% -14.27% (2025) -14.27% -4.71%

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling Aarey Drugs

          What's your call on Aarey Drugs today?

          Read 0 investor views

          BUY SELL HOLD

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          31 Dec, 2025

          Suraj Tradelinks Private Limited

          Qty 381336 Price 67.89 % Traded 1.35
          31 Dec, 2025

          Nishith Atulbhai Shah

          Qty 250000 Price 68.07 % Traded 0.89
          31 Dec, 2025

          Nishith Atulbhai Shah

          Qty 195000 Price 67.74 % Traded 0.69
          31 Dec, 2025

          Black Hawk Properties Private Limited

          Qty 178498 Price 67.79 % Traded 0.63
          31 Dec, 2025

          Shree Gautam Enterprise Private Limited

          Qty 175000 Price 68.08 % Traded 0.62
          31 Dec, 2025

          Share India Securities Limited

          Qty 160000 Price 68 % Traded 0.57
          31 Dec, 2025

          Shree Gautam Enterprise Private Limited

          Qty 4554 Price 68.05 % Traded 0.02
          24 Dec, 2025

          Suraj Tradelinks Private Limited

          Qty 185000 Price 72.48 % Traded 0.65

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          About the Company

          Aarey Drugs & Pharmaceuticals Ltd.is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The Therapeutic targets of the company`s products are Allergy, Dermatology & Infectious Diseases
          {"success":1,"data":{"address":{"address1":"E-34, M.I.D.C.,\n","address2":"Tarapur, \nBoisar,,","city":"Thane","state":"Maharashtra","pincode":"401506","telephone1":"022-2271049","telephone2":"022-2272313","fax1":"022-66154219","fax2":"","email":"investorgrievance@aareydrugs.com","web":"http:\/\/www.aareydrugs.com"},"management":[{"name":"Mihir R Ghatalia","designation":"Chairman & Managing Director"},{"name":"Nimit Rajesh Ghatalia","designation":"Executive Director"},{"name":"Bina Rajesh Ghatalia","designation":"Woman Director"},{"name":"Chetan K Mehta","designation":"Independent Director"},{"name":"Anil Mandal","designation":"Independent Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West),","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"524412","nseId":"AAREYDRUGS","series":"EQ","isinid":"INE198H01019"}}}
          • Registered Office

          • Registrars

          • Management

            • Mihir R Ghatalia

              Chairman & Managing Director

            • Nimit Rajesh Ghatalia

              Executive Director

            • Bina Rajesh Ghatalia

              Woman Director

            • Chetan K Mehta

              Independent Director

            • Anil Mandal

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              524412

            • NSE:

              AAREYDRUGS

            • Series

              EQ

            • ISIN

              INE198H01019

          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347